Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Vilde, JL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 92 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Duval, X; Papastamopoulos, V; Longuet, P; Benoit, C; Perronne, C; Leport, C; Vilde, JL
      Definite Streptococcus bovis endocarditis: characteristics in 20 patients

      CLINICAL MICROBIOLOGY AND INFECTION
    2. Fidouh-Houhou, N; Duval, X; Bissuel, F; Bourbonneux, V; Flandre, P; Ecobichon, JL; Jordn, MC; Vilde, JL; Brun-Vezinet, F; Leport, C
      Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients

      CLINICAL INFECTIOUS DISEASES
    3. Duval, X; Trad, S; Le Moing, V; Longuet, P; Leport, C; Vilde, JL
      Paradoxical aggravation of tuberculosis after antiretroviral treatment in HIV-infected patients

      PRESSE MEDICALE
    4. Maccari, F; Descamps, V; Duval, X; Grossin, M; Vilde, JL; Crickx, B
      Cutaneous manifestations in immune restoration syndrome occurring during tuberculosis therapy

      ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE
    5. Duval, X; Larger, E; Longuet, P; Leport, C; Vilde, JL
      Galactorrhoea, hyperprolactinaemia, and protease inhibitors

      LANCET
    6. Le Moing, V; Eid, Z; Ecobichon, JL; Duval, X; Longuet, P; Elbim, C; Brun-Vezinet, F; Leport, C; Vilde, JL
      Long-term immunologic response in HIV-infected patients with CD4 cell counts <= 50/mm(3) when initiating protease inhibitor therapy.

      ANNALES DE MEDECINE INTERNE
    7. Duval, X; Djendli, S; Le Moing, V; Longuet, P; Barry, B; Leport, C; Vilde, JL
      Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease)

      AMERICAN JOURNAL OF MEDICINE
    8. Vincent, I; D'Herouville, D; Moulin, P; Bugler, C; Fraval, J; Mallet, D; Salamagne, MH; Vilde, JL; Jodelet, D; Leport, C
      Modalities of palliative care in hospitalized patients with advanced AIDS

      AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV
    9. Hubert, JB; Burgard, M; Dussaix, E; Tamalet, C; Deveau, C; Le Chenadec, J; Chaix, ML; Marchadier, E; Vilde, JL; Delfraissy, JF; Meyer, L; Rouzioux, C
      Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

      AIDS
    10. Duval, X; Le Moing, V; Longuet, P; Leport, C; Vilde, JL; Lamotte, C; Peytavin, G; Farinotti, R
      Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    11. Benveniste, O; Dereuddre-Bosquet, N; Clayette, P; Leport, C; Vilde, JL; Dormont, D
      High levels of IL-10 and determination of other cytokines and chemokines in HIV-associated haemophagocytic syndrome

      CLINICAL AND EXPERIMENTAL IMMUNOLOGY
    12. Le Moing, V; Lacassin, F; Delahousse, M; Duval, X; Longuet, P; Leport, C; Vilde, JL
      Use of corticosteroids in glomerulonephritis related to infective endocarditis: Three cases and review

      CLINICAL INFECTIOUS DISEASES
    13. Benveniste, O; Longuet, P; Duval, X; Le Moing, V; Leport, C; Vilde, JL
      Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir

      CLINICAL INFECTIOUS DISEASES
    14. Salmon-Ceron, D; Fillet, AM; Aboulker, JP; Gerard, L; Houhou, N; Carriere, I; Ostinelli, J; Vilde, JL; Brun-Vezinet, F; Leport, C
      Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patientswith persistent CMV viremia

      CLINICAL INFECTIOUS DISEASES
    15. Longuet, P; Duval, X; Le Moing, V; Scanvic-Hameg, A; Leport, C; Vilde, JL
      Antibiotic prophylaxis in patients at risk of a nosocomial outbreak of legionnellosis

      PRESSE MEDICALE
    16. Taille, C; Fournier, PE; Bissuel, F; Longuet, P; Leport, C; Vilde, JL
      Meningoencephalitis during Q fever.

      MEDECINE ET MALADIES INFECTIEUSES
    17. Le Moing, V; Geniteau, M; Lacassin, F; Nicaise, P; Leport, C; Labarre, C; Vilde, JL
      Imbalance of immunoglobulin G subclasses in HIV-infected patients with pneumococcal infection.

      MEDECINE ET MALADIES INFECTIEUSES
    18. Duval, X; Peytavin, G; Fouqueray, B; Leport, C; Vilde, JL
      Renin-angiotensin system inhibition in a patient having an overdose of HIVprotease inhibitor

      AIDS
    19. Francois, B; Duval, X; Le Moing, V; Bruneel, F; Leport, C; Vilde, JL
      Bupivacain-induced meningitis

      REVUE DE MEDECINE INTERNE
    20. Leport, C; Descamps, D; Lacassin, F; Collin, G; Tilly, F; Vilde, JL; Brun-Vezinet, F
      Assessment of codon 215 mutation in 10 patients with slow progression of HIV infection, on long-term zidovudine monotherapy

      MEDECINE ET MALADIES INFECTIEUSES
    21. Leport, C; Perronne, C; Vilde, JL
      Antiviral treatment of varicella in adults and immunocompromised hosts (adults and children)

      MEDECINE ET MALADIES INFECTIEUSES
    22. CHENE G; MORLAT P; LEPORT C; HAFNER R; DEQUAE L; CHARREAU I; ABOULKER JP; LUFT B; AUBERTIN J; VILDE JL; SALAMON R
      INTENTION-TO-TREAT VS. ON-TREATMENT ANALYSES OF CLINICAL-TRIAL DATA -EXPERIENCE FROM A STUDY OF PYRIMETHAMINE IN THE PRIMARY PROPHYLAXIS OF TOXOPLASMOSIS IN HIV-INFECTED PATIENTS

      Controlled clinical trials
    23. MAINARDI JL; LACASSIN F; GUILLOY Y; GOLDSTEIN FW; LEPORT C; ACAR JF; VILDE JL
      LOW-RATE OF CLOSTRIDIUM-DIFFICILE COLONIZATION IN AMBULATORY AND HOSPITALIZED HIV-INFECTED PATIENTS IN A HOSPITAL UNIT - A PROSPECTIVE SURVEY

      The Journal of infection
    24. Benveniste, O; Bruneel, F; Bedos, JP; Wolff, M; Leseche, G; Leport, C; Vilde, JL; Vachon, F; Regnier, B
      Ruptured mycotic pulmonary artery aneurysm: an unusual complication of right-sided endocarditis

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    25. PUEYO S; SALMI LR; CHENE G; LEPORT C; MORLAT P; DEQUAE L; GREGOIRE V; HAFNER R; VILDE JL; LUFT BJ; AUBERTIN J; SALAMON R
      SURVIVAL AFTER AIDS-DEFINING EVENTS IN PATIENTS WITH LESS-THAN-200 LYMPHOCYTES CD4+X10(6) L WHO ARE TOXOPLASMOSIS ANTIBODY-POSITIVE/

      Journal of acquired immune deficiency syndromes and human retrovirology
    26. GERARD L; LEPORT C; FLANDRE P; HOUHOU B; SALMONCERON D; PEPIN JM; MANDET C; BRUNVEZINET F; VILDE JL
      CYTOMEGALOVIRUS (CMV) VIREMIA AND THE CD4(-IMMUNODEFICIENCY-VIRUS() LYMPHOCYTE COUNT AS PREDICTORS OF CMV DISEASE IN PATIENTS INFECTED WITHHUMAN)

      Clinical infectious diseases
    27. ROUSSEAU F; PUEYO S; MORLAT P; HAFNER R; CHENE G; LEPORT C; LUFT BJ; MIRO J; AUBERTIN J; SALAMON R; VILDE JL
      INCREASED RISK OF TOXOPLASMIC ENCEPHALITIS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS WITH PYRIMETHAMINE-RELATED RASH

      Clinical infectious diseases
    28. RAGUIN G; LERUEZVILLE M; GREGOIRE V; DEPLANCHE M; LEPORT C; MORINET F; VILDE JL
      LOW-PREVALENCE OF ACTIVE PARVOVIRUS B19 INFECTION IN HIV-INFECTED PATIENTS

      European journal of clinical microbiology & infectious diseases
    29. DUVAL X; CLAYETTE P; DEREUDDREBOSQUET N; FRETIER P; MARTIN M; SALMONCERON D; GRAS G; VILDE JL; DORMONT D
      DAPSONE AND HIV-1 REPLICATION IN PRIMARY CULTURES OF LYMPHOCYTES AND MONOCYTE-DERIVED MACROPHAGES

      AIDS
    30. DEVINCENZI I; JADAND C; COUTURIER E; BRUNET JB; GALLAIS H; GASTAUT JA; GOUJARD C; DEVEAU C; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; DELLAMONICA P; PERBOST I; CARLES M; MONDAIN V; GUILLEVIN L; JAROUSSE B; TROGOFF B; LEBRAS P; QUERTAINMONT Y; VILDE JL; LEPORT C; COLASSANTE U; KAZATCHKINE M; VELLAY A; BUISSON M; CASSUTO JP; REBOULOT B; SERENI D; GOMEZ V; BACHMEYER C; MARS ME; GALLAIS J; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; KATLAMA C; BRUCKER G; DHIVER C; DROGOUL MP
      PREGNANCY AND CONTRACEPTION IN A FRENCH COHORT OF HIV-INFECTED WOMEN

      AIDS
    31. RAFFI F; ABOULKER JP; MICHELET C; RELIQUET V; PELLOUX H; HUART A; POIZOTMARTIN I; MORLAT P; DUPAS B; MUSSINI JM; LEPORT C; ALLEGRE T; AUBERTIN J; BEYLOT J; CANTON P; AMBROISETHOMAS P; MICOUD M; PEYRAMOND D; TREPO C; GASTAUT JA; JANBON F; BARRIER JH; LITOUX P; DELLAMONICA P; CARBON C; COULAUD JP; VACHON F; VILDE JL; SICARD D; COMPAGNUCCI A; MARSAL L; MODAI J; SELIGMANN M; LANG JM; LAFEUILLADE A
      A PROSPECTIVE-STUDY OF CRITERIA FOR THE DIAGNOSIS OF TOXOPLASMIC ENCEPHALITIS IN 186 AIDS PATIENTS

      AIDS
    32. LACASSIN F; LOUSSERTAJAKA I; LEPORT C; BRUNVEZINET F; VILDE JL; SIMON F
      RAPID FATAL EVOLUTION IN 2 CASES OF INFECTION DUE TO HIV-1 UNCOMMON SUBTYPES IN FRANCE

      AIDS
    33. MEYER L; MAGIEROWSKA M; HUBERT JB; ROUZIOUX C; DEVEAU C; SANSON F; DEBRE P; DELFRAISSY JF; THEODOROU I; BARY M; BURGARD M; DORMONT J; BOUE F; LEVY A; DELLAMONICA P; PERBOST I; CARLES M; MONDAIN V; GUILLEVIN L; JAROUSSE B; TROGOFF B; LEBRAS P; GOUJARD C; QUERTAINMONT Y; VILDE JL; LEPORT C; COLASSANTE U; KAZATCHKINE M; VELLAY A; BUISSON M; CASSUTO JP; REBOULOT B; QUARANTA M; SERENI D; GOMEZ V; BACHMEYER C; GALLAIS H; MARS ME; GALLAIS J; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; KATLAMA C; BRUCKER G; GASTAUT JA; DHIVER C; DROGOUL MP
      EARLY PROTECTIVE EFFECT OF CCR-5 DELTA-32 HETEROZYGOSITY ON HIV-1 DISEASE PROGRESSION - RELATIONSHIP WITH VIRAL LOAD

      AIDS
    34. BARETE S; BISSUEL F; LONGUET P; POCIDALO MA; LEPORT C; VILDE JL
      AGRANULOCYTOSIS IN A PATIENT ON TERBINAFI NE THERAPY

      La Revue de medecine interne
    35. CARRE N; ROBAIN M; DUSSAIX E; SALMONCERON D; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; LEVY A; BOUE F; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLC C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; DELFRAISSY JF; LEBRAS P; GOUJARD C; QUERTAINMONT Y; GUILLEVIN L; JAROUSSE B; TROGOFF B
      SEXUAL FACTORS ASSOCIATED WITH CYTOMEGALOVIRUS SEROPOSITIVITY IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED MEN

      Sexually transmitted diseases
    36. EDELMAN L; DEVEAU C; RAPHAEL M; MONCHATRE E; GABARRE J; DEVILLECHABROL A; PIALOUX G; EMILIE D; JOAB I; GALANAUD P; ROUZIOUX C; BARY M; BURGARD M; GALLAIS H; MARS ME; GALLAIS J; DELLAMONICA P; PERBOST I; CARLES M; CASSUTO JP; REBOULOT B; QUARANTA M; LEFRERE JJ; LERABLE J; JOUBERT L; DUPONT B; BEUZELIN C; FOURNIER S; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; VITTECOQ D; BOLLIOT C; PECHALAT MT; LEBRAS P; GOUJARD C; QUERTAINMONT Y; GASTAUT JA; DHIVER C; DROGOUL MP; GAZENGEL C; PERTUISSET N; ROTSCHILD M; HERSON S; COUTELLIER A; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; PEYNET J; LAUX C; KATLAMA C; BRUCKER G; LAURIAN Y; KEBEDJI L; LAMBERT T; SOBEL A; DUVAL J; MAJERHOLE C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; SULTAN Y; GAUTREAU C; PICARD F; GUILLEVIN L; LAROUSSE B; TROGOFF B
      SERUM INTERLEUKIN-10 IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME LYMPHOMA PATIENTS

      European cytokine network
    37. FLANDRE P; BOUFASSA F; GERARD L; CARRE N; PERSOZ A; MEYER L; ROUZIOUX C; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; VILDE JL; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLD C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; LEBRAS P; GOUJARD C; QUERTAINMONT Y; ANDRIEU JM; EVEN P; GUILLEVIN L; JAROUSSE B; TROGOFF B
      THE USE OF AUXILIARY EVENTS TO IMPROVE THE ANALYSIS OF SURVIVAL FOR HIV-INFECTED PATIENTS - APPLICATION TO THE FRENCH PROSPECTIVE MULTICENTER COHORT (SEROCO)

      Journal of acquired immune deficiency syndromes and human retrovirology
    38. DAUTZENBERG B; OLLIARO P; RUF B; ESPOSITO R; OPRAVIL M; HOY JF; ROZENBAUM W; CAROSI GP; MICOUD M; LAGE M; PIROTTA N; SASSELLA D; COULAUD JP; VILDE JL; GENTILINI M; CAUBARRERE I; CAQUET R; WEINBRECK P; LEBEAU B; HUMBERT G; MODAI J; ARMENGAUD M; DUFFAUT M; DUJARDIN P; DELLAMONICA P; MOUTON Y; GALLAIS H; GASTAUD JA; GENIAUX M; SUERI L; BARNI C; CALIGARIS S; ELHAMAD I; ERRANTE I; MORONI M; FRANZETTI F; CARGNEL A; DEDIVITIIS GF; MARONE P; PASTICCI MB; HELM EB; RUHNKE M; SCHURMANN D; SCHULER W; ERCKENBRECHT I; HEISE W; BROCKMEYER N; DIETRICH M; JONES P; GROSSET J; PENATI V; MAUCH H; SALFINGER M; DWYER B; GILBERT L; DESLANDES JY; DOLFI L; GLANZMANN I; HARRIS M; HERCEG R; LANDI V; MORELLI P; SCOLA E; WEINIG S; KUNIN MC; CARBON NC; GRASSI G; NORRBY SR; POCOCK SJ
      RIFABUTIN VERSUS PLACEBO IN COMBINATION WITH 3 DRUGS IN THE TREATMENTOF NONTUBERCULOUS MYCOBACTERIAL INFECTION IN PATIENTS WITH AIDS

      Clinical infectious diseases
    39. GERARD L; FLANDRE P; RAGUIN G; LEGALL JR; VILDE JL; LEPORT C
      LIFE EXPECTANCY IN HOSPITALIZED-PATIENTS WITH AIDS - PROGNOSTIC FACTORS ON ADMISSION

      Journal of palliative care
    40. VILDE JL
      A WORD FROM THE EDITOR

      La Presse medicale
    41. LEPORT C; AMBROISETHOMAS P; BAZIN C; CHENE G; DEROUIN F; KATLAMA C; MAYAUD C; PELLOUX H; RAFFI F; VILDE JL
      RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DEFINITION OF INDICATIONS FOR PRIMARY PROPHYLAXIS - PRPOSALS OF THE PE-TOXOPLASMOSE-ET-AUTRES-INFECTIONS-A-PROTOZOAIRE

      La Presse medicale
    42. DEROUIN F; LEPORT C; PUEYO S; MORLAT P; ECOBICHON JL; LETRILLART B; CHENE G; LUFT B; AUBERTIN J; HAFNER R; VILDE JL; SALAMON R
      PREDICTIVE VALUE OF TOXOPLASMA-GONDII ANTIBODY-TITERS ON THE OCCURRENCE OF TOXOPLASMIC ENCEPHALITIS IN HIV-INFECTED PATIENTS

      AIDS
    43. CARRE N; MEYER L; BOUFASSA F; DEVEAU C; PERSOZ A; ROUZIOUX C; VILDE JL; BARY M; BURGARD M; DELLAMONICA P; DURANT J; GALLAIS H; MARS ME; GALLAIS J; DORMONT J; DELFRAISSY JF; LEVY A; BOUE F; BECLERE A; LEFRERE JJ; LERABLE J; JOUBERT L; CASSUTO JP; REBOULOT B; QUARANTA M; DUPONT B; BEUZELIN C; FOURNIER S; VITTECOQ D; BOLLIOT C; PECHALAT MT; HERSON S; COUTELLIER A; GASTAUT JA; DHIVER C; DROGOUL MP; SERENI D; GOMEZ V; BACHMEYER C; LEPORT C; COLASSANTE U; KATLAMA C; BRUCKER G; SOBEL A; DUVAL J; MAJERHOLC C; DEFORGES L; KAZATCHKINE M; VELLAY A; BUISSON M; LEBRAS P; GOUJARD C; QUERTAINMONT Y; ANDRIEU JM; EVEN P; GUILLEVIN L; JAROUSSE J; TROGOFF B
      HIGH-RISK OF HIV DISEASE PROGRESSION AFTER INFECTION THROUGH A SEXUALPARTNER WITH AIDS

      AIDS
    44. BISSUEL F; HOUHOU N; LEPORT C; BRUNVEZINET F; VILDE JL
      HEPATITIS-E ANTIBODIES AND HIV STATUS

      Lancet
    45. LACASSIN F; DAMOND F; CHOCHILLON C; LONGUET P; LEBRAS J; VILDE JL; LEPORT C
      RESPONSE TO FLUCONAZOLE BY 23 PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND ORAL CANDIDIASIS - PHARMACOLOGICAL AND MYCOLOGICAL FACTORS

      Antimicrobial agents and chemotherapy
    46. LONGUET P; GERARD L; VILDE JL
      CYTOMEGALOVIRUS DISEASE

      La Semaine des hopitaux de Paris
    47. VILDE JL; SALMONCERON D
      IRON OVERLOAD AS A MECHANISM FOR THE LOWERED SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE-IRON PROTOXALATE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA - REPLY

      The Journal of infectious diseases
    48. VILDE JL; SALMONCERON D
      RANDOMIZATION TO IRON SUPPLEMENTATION OF PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE - AN INADVERTENT BUT CONTROLLED-STUDY WITH RESULTS IMPORTANT FOR PATIENT-CARE - REPLY

      The Journal of infectious diseases
    49. LEPORT C; CHENE G; MORLAT P; LUFT BJ; ROUSSEAU F; PUEYO S; HAFNER R; MIRO J; AUBERTIN J; SALAMON R; VILDE JL; BLANC AP; SCHMITT JL; ARLAUD J; ESTAVOYER JM; GUILLEVIN L; BENTATA M; BEYLOT J; LACUT JY; GRANIER P; COSNARD F; BAZIN C; DORMONT J; REY M; DELAUNAY C; TROISVALLET D; MICOUD M; WEINBRECK P; TREPO C; GALLAIS H; GASTAUT JA; ALLARD C; JANBON F; CANTON P; GROLLEAU JY; CASSUTO J; DELLAMONICA P; DURET P; FROTTIER J; HERSON S; SELIGMANN M; SERENI D; GIRAUDON BB; DIEN G; RUEL M; STORCK D; JAUBERT D; LAFEUILLADE A; MOUTON Y; CHOUTET P; LAFAIX C; GATELL JM; GUELAR A; MILDVAN D; SOIERO R; JACOBSON JM; MURRAY HW; STEIGBIGEL NH; SACHS HH; VALENTINE F; GRIECO MH; ARMSTRONG D; LEDERMAN M; BARTLETT JA; WASKIN HA; NICHOLAS P; FESSEL JW; MACARTHUR RD; GLATT AE; PHAIR JP; POWDERLY W; HEWITT R; STEIGBIGEL RT; BLAIR DC; SKAHAN KJ; FRAME P; CHEESEMAN SH; CONNOR EM; BALFOUR HH; VANDERHORST C; HO M
      PYRIMETHAMINE FOR PRIMARY PROPHYLAXIS OF TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - A DOUBLE-BLIND,RANDOMIZED TRIAL

      The Journal of infectious diseases
    50. SALMONCERON C; FONTBONNE A; SABA J; MAY T; RAFFI F; CHIDIAC C; PATEY O; ABOULKER JP; SCHWARTZ D; VILDE JL
      LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA (VOL 172, PG 656, 1995)

      The Journal of infectious diseases
    51. LEPORT C; AMBROISETHOMAS P; BAZIN C; CHENE G; DEROUIN F; KATLAMA C; MAYAUD C; PELLOUX H; RAFFI F; VILDE JL
      RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N HIV-INFECTED PATIENTS - DEFINING INDICATIONS FOR PRIMARY PROPHYLAXIS

      Annales de medecine interne
    52. VILDE JL
      INFECTIOUS-DISEASES TODAY AND TOMORROW

      La Presse medicale
    53. DUVAL X; PATY MC; LONGUET P; LACASSIN F; PERRONNE C; LEPORT C; VILDE JL
      ACUTE PNEUMOCOCCAL PNEUMONIAE IN HIV-INFE CTED PATIENTS - CLINICAL-FEATURES AND EVOLUTION IN 27 PATIENTS

      La Presse medicale
    54. ASSAN R; PERRONNE C; CHOTARD L; LARGER E; VILDE JL
      MEFLOQUINE-ASSOCIATED HYPOGLYCEMIA IN A CACHECTIC AIDS PATIENT

      Diabete et metabolisme
    55. LUCASSIN F; MINO JC; BENOIT C; PERRONNE C; LEPORT C; VILDE JL
      ONE CASE OF FOWL SALMONELLOSIS

      La Revue de medecine interne
    56. STRUILLOU L; COHEN Y; LOUNIS N; BERTRAND G; GROSSET J; VILDE JL; POCIDALO JJ; PERRONNE C
      ACTIVITIES OF ROXITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM INFECTIONS INHUMAN MACROPHAGES AND C57BL 6 MICE/

      Antimicrobial agents and chemotherapy
    57. STRUILLOU L; COHEN Y; VILDE JL; POCIDALO JJ; PERRONNE C
      GINKGO-BILOBA EXTRACT EGB-761 IS NOT ACTIVE AGAINST MYCOBACTERIUM-AVIUM INFECTION IN C57BL 6 MICE/

      Antimicrobial agents and chemotherapy
    58. COHEN Y; PERRONNE C; LAZARD T; TRUFFOTPERNOT C; GROSSET J; VILDE JL; POCIDALO JJ
      USE OF NORMAL C57BL 6 MICE WITH ESTABLISHED MYCOBACTERIUM-AVIUM INFECTIONS AS AN ALTERNATIVE MODEL FOR EVALUATION OF ANTIBIOTIC-ACTIVITY/

      Antimicrobial agents and chemotherapy
    59. LACASSIN F; SCHAFFO D; PERRONNE C; LONGUET P; LEPORT C; VILDE JL
      CLARITHROMYCIN-MINOCYCLINE COMBINATION AS SALVAGE THERAPY FOR TOXOPLASMOSIS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      Antimicrobial agents and chemotherapy
    60. SALMONCERON D; FONTBONNE A; SABA J; MAY T; RAFFI F; CHIDIAC C; PATEY O; ABOULKER JP; SCHWARTZ D; VILDE JL
      LOWER SURVIVAL IN AIDS PATIENTS RECEIVING DAPSONE COMPARED WITH AEROSOLIZED PENTAMIDINE FOR SECONDARY PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA

      The Journal of infectious diseases
    61. BOUFASSA F; BACHMEYER C; CARRE N; DEVEAU C; PERSOZ A; JADAND C; SERENI D; BUCQUET D; ROUZIOUX C; DELLAMONICA P; GALLAIS H; DELFRAISSY JF; LEFRERE JJ; CASSUTO JP; DUPONT B; VITTECOQ D; HERSON S; GASTAUT JA; VILDE JL; KATLAMA C; SOBEL A; DUVAL J; KAZATCHKINE M; LEBRAS P; EVEN P; GUILLEVIN L; MEYER L; DEVEAU C
      INFLUENCE OF NEUROLOGIC MANIFESTATIONS OF PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION ON DISEASE PROGRESSION

      The Journal of infectious diseases
    62. LONGUET P; LORTHOLARY O; BENOIT C; LEPORT C; VILDE JL
      ESCHERICHIA-COLI BACTEREMIA AND CELLULITI S IN AIDS - 2 CASE-REPORTS

      Annales de medecine interne
    63. LORTHOLARY O; LISOVOSKI F; BRECHOT JM; LONGUET P; PERRONNE C; LEPORT C; VILDE JL
      MYELITIS DUE TO TOXOPLASMA-GONDII IN A PATIENT WITH AIDS

      Clinical infectious diseases
    64. PERRONNE C; SABA J; BEHLOUL Z; SALMONCERON D; LEPORT C; VILDE JL; KAHN MF
      PYOGENIC AND TUBERCULOUS SPONDYLODISKITIS (VERTEBRAL OSTEOMYELITIS) IN 80 ADULT PATIENTS

      Clinical infectious diseases
    65. ANGLARET X; SABA J; PERRONNE C; LACASSIN F; LONGUET P; LEPORT C; VILDE JL
      EMPIRIC ANTITUBERCULOSIS TREATMENT - BENEFITS FOR EARLIER DIAGNOSIS AND TREATMENT OF TUBERCULOSIS

      Tubercle and lung disease
    66. LAZARD T; PERRONNE C; TRUFFOTPERNOT C; GROSSET J; VILDE JL; POCIDALO JJ
      CHLOROQUINE DOES NOT ENHANCE THE ACTIVITY OF CLARITHROMYCIN AGAINST MULTIPLICATION OF MYCOBACTERIUM-AVIUM WITHIN HUMAN MACROPHAGES

      Tubercle and lung disease
    67. BISSUEL F; LEPORT C; PERRONNE C; LONGUET P; VILDE JL
      FEVER OF UNKNOWN ORIGIN IN HIV-INFECTED PATIENTS - A CRITICAL ANALYSIS OF A RETROSPECTIVE SERIES OF 57 CASES

      Journal of internal medicine
    68. BUCQUET D; DEVEAU C; BELANGER F; BOUFASSA F; DESMOULINS C; JADAND C; CARRE N; LEIBOVICI D; VILDE JL; ROUZIOUX C; SPIRA A; SCHWARTZ D; DORMONT J; MAYAUX M; DELLAMONICA P; GALLAIS H; LEFRERE JJ; CASSUTO JP; DUPONT B; VITTECOQ D; HERSON S; GASTAUT JA; SERENI D; BRUCKER G; KATLAMA C; SOBEL A; DUVAL J; KAZATCHINE M; LEBRAS P; EVEN P; GUILLEVIN L
      PROSPECTIVE FOLLOW-UP OF HIV-INFECTED ADU LTS - 4-YEAR REPORT OF THE MULTICENTRIC FRENCH COHORT

      La Presse medicale
    69. LEPORT C; AMBROISETHOMAS P; CHENE G; DEROUIN F; KATLAMA C; RAFFI F; VILDE JL
      UPDATE ON CONSENSUAL PROPOSITIONS - COTRI MOXAZOLE AS PRIMARY PROPHYLAXIS FOR TOXOPLASMOSIS IN HIV-INFECTED PATIENTS - UP-ON-TOXOPLASMOSIS-AND-OTHER-PROTOZOAL-INFECTIONS - COORDINATING ACTION N5-ANRS

      Medecine et maladies infectieuses
    70. CARRE N; DEVEAU C; BELANGER F; BOUFASSA F; PERSOZ A; JADAND C; ROUZIOUX C; DELFRAISSY JF; BUCQUET D; DELLAMONICA P; GALLAIS H; DORMONT J; LEFRERE JJ; CASSUTO JP; DUPONT B; VITTECOQ D; HERSON S; GASTAUT JA; SERENI D; VILDE JL; BRUCKER G; KATLAMA C; SOBEL A; DUVAL J; KAZATCHINE M; LEBRAS P; EVEN P; GUILLEVIN L
      EFFECT OF AGE AND EXPOSURE GROUP ON THE ONSET OF AIDS IN HETEROSEXUALAND HOMOSEXUAL HIV-INFECTED PATIENTS

      AIDS
    71. MENTEC H; LEPORT C; LEPORT J; MARCHE C; HARZIC M; VILDE JL
      CYTOMEGALOVIRUS COLITIS IN HIV-1-INFECTED PATIENTS - A PROSPECTIVE RESEARCH IN 55 PATIENTS

      AIDS
    72. WALCKENAER G; LEPORT C; LONGUET P; PERRONNE C; LACASSIN F; VILDE JL
      RELAPSE OF BRAIN TOXOPLASMOSIS IN 15 AIDS PATIENTS

      Annales de medecine interne
    73. LORTHOLARY O; ROZENBERG F; PERRONNE C; DJEBBOUR S; LEPORT C; VILDE JL
      HERPES-SIMPLEX VIRUS TYPE-2 DNA IN CEREBROSPINAL-FLUID OF A WOMAN WITH RECURRENT MENINGITIS

      Clinical infectious diseases
    74. ROUSSEAU F; PERRONNE C; RAGUIN G; THOUVENOT D; VIDAL A; LEPORT C; VILDE JL
      NECROTIZING RETINITIS AND CEREBRAL VASCULITIS DUE TO VARICELLA-ZOSTERVIRUS IN PATIENTS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS

      Clinical infectious diseases
    75. CAMUS C; LEPORT C; RAFFI F; MICHELET C; CARTIER F; VILDE JL
      SUSTAINED BACTEREMIA IN 26 PATIENTS WITH A PERMANENT ENDOCARDIAL PACEMAKER - ASSESSMENT OF WIRE REMOVAL

      Clinical infectious diseases
    76. LORTHOLARY O; PERRONNE C; LEPORT J; LEPORT C; VILDE JL
      PRIMARY CYTOMEGALOVIRUS-INFECTION ASSOCIATED WITH THE ONSET OF ULCERATIVE-COLITIS

      European journal of clinical microbiology & infectious diseases
    77. ROUSSEAU F; PERRONNE C; DENY P; MESTASSI R; LARAKI H; MARCHE C; LEPORT C; VILDE JL
      PROLONGED AND FATAL DISSEMINATED CYTOMEGALOVIRUS-INFECTION IN AN IMMUNOCOMPETENT WOMAN

      European journal of clinical microbiology & infectious diseases
    78. SABA J; MORLAT P; RAFFI F; HAZEBROUCQ V; JOLY V; LEPORT C; VILDE JL
      PYRIMETHAMINE PLUS AZITHROMYCIN FOR TREATMENT OF ACUTE TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH AIDS

      European journal of clinical microbiology & infectious diseases
    79. LONGUET P; VALLEE E; MICHEL M; PERRONNE C; JANVIER M; LEPORT C; VILDE JL
      VANCOMYCIN IN MENINGITIS CAUSED BY PENICI LLIN G-RESISTANT STREPTOCOCCUS-PNEUMONIAE

      La Presse medicale
    80. LACASSIN F; LONGUET P; PERRONNE C; LEPORT C; GEHANNO P; VILDE JL
      BACTERIAL SINUSITIS IN HIV-INFECTION - CLINICAL AND THERAPEUTIC DATA IN 20 PATIENTS

      La Presse medicale
    81. PUEYO S; LEPORT C; CHENE G; MORLAT P; HAFNER R; VILDE JL; LUFT B; SALAMON R; AUBERTIN J
      RISK-FACTORS FOR CEREBRAL TOXOPLASMOSIS I N PATIENTS WITH HIV-INFECTIONS - DATA ON A PRIMARY-PROPHYLAXIS TRIAL

      La Revue de medecine interne
    82. MORLAT P; CHENE G; LEPORT C; ROUSSEAU F; LUFT B; AUBERTIN J; HAFNER R; SALAMON R; VILDE JL
      PRIMARY PROPHYLAXIS OF CEREBRAL TOXOPLASM OSIS IN THE HIV PATIENT - RESULTS OF A DOUBLE-BLIND RANDOMIZED TRIAL (PYRIMETHAMINE VERSUS PLACEBO)

      La Revue de medecine interne
    83. LONGUET P; BARTHIER S; BEUSCART C; LEPORT C; VILDE JL
      MEDICAL CONFIDENTIALITY AND HIV-INFECTION

      Lancet
    84. LAZARD T; PERRONNE C; GROSSET J; VILDE JL; POCIDALO JJ
      CLARITHROMYCIN, MINOCYCLINE, AND RIFABUTIN TREATMENTS BEFORE AND AFTER INFECTION OF C57BL 6 MICE WITH MYCOBACTERIUM-AVIUM/

      Antimicrobial agents and chemotherapy
    85. LAZARD T; PERRONNE C; GROSSET J; VILDE JL; POCIDALO JJ
      CLARITHROMYCIN, MINOCYCLINE, AND RIFABUTIN TREATMENTS BEFORE AND AFTER INFECTION OF C57BL 6 MICE WITH MYCOBACTERIUM-AVIUM (VOL 37, PG 1690,1993)/

      Antimicrobial agents and chemotherapy
    86. VILDE JL
      INFECTIOUS AND RENAL PATHOLOGY IN MAGHREB

      La Semaine des hopitaux de Paris
    87. LUFT BJ; HAFNER R; KORZUN AH; LEPORT C; ANTONISKIS D; BOSLER EM; BOURLAND DD; UTTAMCHANDANI R; FUHRER J; JACOBSON J; MORLAT P; VILDE JL; REMINGTON JS
      TOXOPLASMIC ENCEPHALITIS IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      The New England journal of medicine
    88. LEPORT C; PUGET S; PEPIN JM; LEVY S; PERRONNE C; BRUNVEZINET F; VILDE JL
      CYTOMEGALOVIRUS RESISTANT TO FOSCARNET - CLINICOVIROLOGIC CORRELATIONIN A PATIENT WITH HUMAN-IMMUNODEFICIENCY-VIRUS

      The Journal of infectious diseases
    89. LEPORT C; AMBROISETHOMAS P; CHENE G; KATLAMA C; RAFFI F; VILDE JL
      CONSENSUAL PROPOSALS FOR THE TREATMENT OF TOXOPLASMOSIS IN PATIENTS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUSES

      Annales de medecine interne
    90. LEPORT C; AMBROISETHOMAS P; CHENE G; DEROUIN F; KATLAMA C; RAFFI F; VILDE JL
      UPDATE ON THE CONSENSUAL PROPOSITIONS CONCERNING THE USE OF COTRIMOXAZOLE AS PRIMARY PROPHYLAXIS AGAINST TOXOPLASMOSIS IN PATIENTS INFECTEDWITH THE IMMUNODEFICIENCY VIRUSES

      Annales de medecine interne
    91. SALEHIAN B; NIYONGABO T; SALMON D; VILDE JL; MELCHIOR JC; RIGAUD D; KAYAT D; SOUBRANE C
      TUMOR-NECROSIS-FACTOR AND RESTING ENERGY-EXPENDITURE DURING THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME

      The American journal of clinical nutrition
    92. MELCHIOR JC; RAGUIN G; BOULIER A; BOUVET E; RIGAUD D; MATHERON S; CASALINO E; VILDE JL; VACHON F; COULAUD JP; APFELBAUM M
      RESTING ENERGY-EXPENDITURE IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED PATIENTS - COMPARISON BETWEEN PATIENTS WITH AND WITHOUT SECONDARY INFECTIONS

      The American journal of clinical nutrition


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 29/10/20 alle ore 15:33:30